PhaBuilder
PrivateLast Round
Series A
Extension
Feb 1, 2023
Est. Valuation
$291.97M
Total Funding Raised
$99.5M
Company Overview
PhaBuilder operates in Frontier & Industrial Tech and is based in Beijing. Its latest recorded funding round was a Series A Extension round in February 2023.
PhaBuilder is a synthetic biology company that produces Polyhydroxyalkanoate (PHA), a biodegradable material used as an alternative to plastics for applications in packaging, medical devices, and consumer goods.
Sector
Frontier & Industrial Tech
Verticals
Advanced Materials, Biotechnology, Sustainable Materials, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PhaBuilder Comparables
Compare PhaBuilder with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bluepha | 91% | |
| RWDC Industries | 82% | |
| Biomer | 82% |
For institutional investors. Book with your work email.
PhaBuilder Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Feb 1, 2023 | ||||
| Series A | Jan 17, 2022 | ||||
| Angel | Jul 26, 2021 |
For institutional investors. Book with your work email.
PhaBuilder Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shanghai FTZ Fund | Series A Extension |
| Zhonghai Investment | Series A Extension, Series A |
| GRC SinoGreen | Series A Extension, Series A |
| Shenzhen Guozhong Venture Capital Management | Series A |
| 北京启航创业投资管理有限公司 | Angel |
| CNPC Kunlun Capital | Series A Extension |
| Beijing Shuimu Huading Venture Capital Management Co., Ltd. | Angel |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Open roles increased to 18, 3x the trailing average.
- Sep 7, 2024
Grew 21% QoQ from 14 to 17 employees.
For institutional investors. Book with your work email.
PhaBuilder Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PhaBuilder's valuation, stock price, and market status.
Is PhaBuilder a public or private company?
PhaBuilder is a private company.
What is the current stock price of PhaBuilder?
PhaBuilder is a private company, so its shares have no public market price. Caplight tracks PhaBuilder's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PhaBuilder worth (valuation)?
PhaBuilder's valuation is estimated at $292.0M based on funding round data.
Can I buy PhaBuilder stock?
PhaBuilder shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PhaBuilder's last funding round?
PhaBuilder's most recent funding round was Series A Extension on February 1, 2023.
Who are the main investors in PhaBuilder?
Key investors in PhaBuilder include CNPC Kunlun Capital, HongShan Capital Group (HSG).
Will PhaBuilder IPO soon?
No public IPO plans have been announced for PhaBuilder.
How can I track PhaBuilder secondary market activity?
Caplight tracks bids, offers, and trades in PhaBuilder's shares on secondary markets.